Next Article in Journal
CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
Previous Article in Journal
Juggling between the Cost and Value of New Therapies: Does Science Still Serve Patient Needs?
 
 
Review

Article Versions Notes

Thalass. Rep. 2023, 13(1), 38-50; https://doi.org/10.3390/thalassrep13010005
Action Date Notes Link
article xml file uploaded 30 January 2023 08:21 CET Original file -
article xml uploaded. 30 January 2023 08:21 CET Update https://www.mdpi.com/2039-4365/13/1/5/xml
article pdf uploaded. 30 January 2023 08:21 CET Version of Record https://www.mdpi.com/2039-4365/13/1/5/pdf
article html file updated 30 January 2023 08:22 CET Original file -
article html file updated 1 March 2023 11:41 CET Update -
article html file updated 8 March 2023 20:15 CET Update https://www.mdpi.com/2039-4365/13/1/5/html
Back to TopTop